# Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer

> **NCT03301454** · PHASE2 · TERMINATED · sponsor: **Centre Oscar Lambret** · enrollment: 15 (actual)

## Conditions studied

- Esophageal Cancer, Squamous Cell

## Interventions

- **DRUG:** pursuit of chemotherapy

## Key facts

- **NCT ID:** NCT03301454
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-20
- **Primary completion:** 2022-07-05
- **Final completion:** 2022-07-05
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** This decision was taken on June 20 2022 due to low recruitment over the past 4 years.
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03301454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03301454, "Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03301454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*